1. A Long-Term Spinal Intramedullary Response to Ceritinib in ALK Rearranged Non–Small-Cell Lung Cancer. Issue 6 (June 2015) Authors: Biya, Josette; Caramella, Caroline; Lindsay, Colin R.; Planchard, David; Besse, Benjamin Journal: Journal of thoracic oncology Issue: Volume 10:Issue 6(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Long-Term Spinal Intramedullary Response to Ceritinib in ALK Rearranged Non–Small-Cell Lung Cancer. Issue 6 (June 2015) Authors: Biya, Josette; Caramella, Caroline; Lindsay, Colin R.; Planchard, David; Besse, Benjamin Journal: Journal of thoracic oncology Issue: Volume 10:Issue 6(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A microsimulation model to assess the economic impact of immunotherapy in non-small cell lung cancer. Issue 2 (19th April 2020) Authors: Legoupil, Clémence; Debieuvre, Didier; Marabelle, Aurelien; Michiels, Stefan; Kapso, Raïssa; Besse, Benjamin; Bonastre, Julia Journal: ERJ open research Issue: Volume 6:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A phase 1b study of necitumumab in combination with abemaciclib in patients with stage IV non-small cell lung cancer. (November 2019) Authors: Besse, Benjamin; Barlesi, Fabrice; Demedts, Ingel; Fuentes Pradera, Jose; Robinet, Gilles; Gazzah, Anas; Soldatenkova, Victoria; Frimodt-Moller, Bente; Kim, Jong Seok; Vansteenkiste, Johan Journal: Lung cancer Issue: Volume 137(2019) Page Start: 136 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A phase IB dose-escalation study of the safety and pharmacokinetics of pictilisib in combination with either paclitaxel and carboplatin (with or without bevacizumab) or pemetrexed and cisplatin (with or without bevacizumab) in patients with advanced non–small cell lung cancer. (November 2017) Authors: Soria, Jean-Charles; Adjei, Alex A.; Bahleda, Rastilav; Besse, Benjamin; Ferte, Charles; Planchard, David; Zhou, Jing; Ware, Joseph; Morrissey, Kari; Shankar, Geetha; Lin, Wei; Schutzman, Jennifer L.; Dy, Grace K.; Groen, Harry J.M. Journal: European journal of cancer Issue: Volume 86(2017) Page Start: 186 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Absence of significant clinical benefit for a systematic routine creatine phosphokinase measurement in asymptomatic patients treated with anti-programmed death protein (ligand) 1 immune checkpoint inhibitor to screen cardiac or neuromuscular immune-related toxicities. (November 2021) Authors: Hajem, Samia; Ederhy, Stéphane; Champiat, Stéphane; Troalen, Frédéric; Nolin-Lapalme, Alexis; Berhoune, Malik; Cauquil, Cécile; Martin-Romano, Patricia; Baldini, Capucine; Laparra, Ariane; Vuagnat, Perrine; Hollebecque, Antoine; Mateus, Christine; Besse, Benjamin; Naltet, Charles; Robert, Carolin... Journal: European journal of cancer Issue: Volume 157(2021) Page Start: 383 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Abstracts Presented by Attendees. (February 2016) Authors: Remon, Jordi; Lacroix, Ludovic; Planchard, David; Pannet, Chloe; Jovelet, Cecile; Lawson, Andrew; Smalley, Sarah; Howarth, Kevin; Gale, David; Green, Emma; Plagnol, Vincent; Rosenfeld, Nicolas; Soria, Jean‐Charles; Besse, Benjamin Journal: Journal of thoracic oncology Issue: Volume 11(2016) Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. ALK Inhibitors in ALK-positive NSCLC with Central Nervous System Metastases. Issue 1 (2020) Authors: Aldea, Mihaela; Besse, Benjamin; Hendriks, Lizza EL Journal: European oncology & haematology Issue: Volume 16:Issue 1(2020) Page Start: 18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Analysis of the association between prospectively collected immune-related adverse events and survival in patients with solid tumor treated with immune-checkpoint blockers, taking into account immortal-time bias. (November 2022) Authors: Kfoury, Maria; Najean, Marie; Lappara, Ariane; Voisin, Anne-Laure; Champiat, Stéphane; Michot, Jean-Marie; Laghouati, Salim; Robert, Caroline; Besse, Benjamin; Soria, Jean-Charles; Lambotte, Olivier; Massard, Christophe; Marabelle, Aurélien; Texier, Matthieu Journal: Cancer treatment reviews Issue: Volume 110(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Anti-tumour effect of low molecular weight heparin in localised lung cancer: a phase III clinical trial. Issue 4 (4th October 2018) Authors: Meyer, Guy; Besse, Benjamin; Doubre, Hélène; Charles-Nelson, Anaïs; Aquilanti, Sandro; Izadifar, Armine; Azarian, Reza; Monnet, Isabelle; Lamour, Corinne; Descourt, Renaud; Oliviero, Gérard; Taillade, Laurent; Chouaid, Christos; Giraud, Frederique; Falcoz, Pierre-Emmanuel; Revel, Marie-Pierre; We... Journal: European respiratory journal Issue: Volume 52:Issue 4(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗